Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
7793 participants
OBSERVATIONAL
2005-04-30
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Describe the clinical and demographic characteristics of patients who undergo knee arthroplasty and document post operative outcomes.
Examine the relationship between processes of care, hospital and surgeon associated outcomes.
Provide expanded data to characterize existing and evolving practice patterns, delivery of care, and resource utilization in the management of knee arthroplasty patients.
Analyze and design ancillary studies to address unanswered questions.
Disseminate findings through publication in peer-reviewed scientific journals.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Total Hip Registry
NCT01133249
Total Knee Arthroplasty Biomechanics
NCT03671954
Anterior Referencing Versus Posterior Referencing in Minimally Invasive Total Knee Arthroplasty
NCT01135030
Comparison of Restricted Versus Unrestricted Kinematic Alignment in 1ry TKA
NCT06726993
Outcomes Following Total Knee Arthroplasty
NCT02364011
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study Design: Prospective, consecutive series on an unlimited number of patients.
Data Collection
Clinic Data:
Patient Demographics- age, weight, height, gender, affected side, co-morbidities, current medications, and contact information Knee Society Score SF-12 Evaluation of radiographs- AP, ML, and merchant view Preop lab results
Surgical Data:
Surgical approach ASA level Size of implants, catalog and lot numbers Time of surgery Estimated blood loss (ml) Length of incision (cm) Intraoperative ROM Any peculiar findings (i.e. heterotopic bone, large osteophytes, etc.) Preop lab results
Postoperative Data Sf-12 Modified Knee Society Score Quad strength testing Evaluation of radiographs, AP, ML, and merchant view
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
knee arthroplasty
any knee joint arthroplasty device
Cohort consist of all consented patients receiving knee arthroplasty
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
any knee joint arthroplasty device
Cohort consist of all consented patients receiving knee arthroplasty
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient requires a knee arthroplasty, revision knee arthroplasty, or unicondylar knee arthroplasty
3. Patient has signed and dated an IRB approved consent form.
4. Patient is able and willing to participate in the study according to the protocol for the full length of expected term of follow-up, and to follow their physician's directions.
5. Patient has failed to respond to conservative treatment modalities.
Exclusion Criteria
2. Patient is a prisoner.
21 Years
93 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
DePuy Orthopaedics
INDUSTRY
Stryker Orthopaedics
INDUSTRY
Restor3D
INDUSTRY
Heekin Orthopedic Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
R. David Heekin, MD
R. David Heekin, M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard D Heekin, MD
Role: PRINCIPAL_INVESTIGATOR
Heekin Orthopedic Specialists
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Heekin Orthopedic Specialists
Jacksonville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
05-05-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.